Sp-cAMPS sodium salt

Modify Date: 2025-08-21 20:34:30

Sp-cAMPS sodium salt Structure
Sp-cAMPS sodium salt structure
Common Name Sp-cAMPS sodium salt
CAS Number 142439-95-0 Molecular Weight 367.253
Density N/A Boiling Point N/A
Molecular Formula C10H11N5NaO5PS Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Sodium (2S,4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-7-hydroxytetr ahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2-thiolate 2-oxide
Synonym More Synonyms

 Sp-cAMPS sodium salt Biological Activity

Description Sp-cAMPS sodium salt, a cAMP analog, is potent activator of cAMP-dependent PKA I 和 PKA II. Sp-cAMPS sodium salt is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS sodium salt binds the PDE10 GAF domain with an EC50 of 40 μM[1][2][3].
Related Catalog
Target

PKA I

PKA II

PDE3A:47.6 μM (Ki)

PDE10 GAF domain:50 μM (EC50)

In Vitro Treatment of hepatocytes with Sp-cAMPS, the stimulatory diastereomer of adenosine cyclic 3',5'-phosphorothioate, mimics the response seen with glucagon. The glucagon-stimulated increases in the level of Ca2+ can be mimicked by Sp-cAMPS[4].
In Vivo In chronic alcohol consumption (CAC) mice, direct infusion of the Sp-cAMPS (1 µg/µL) into the prefrontal cortex significantly improves or impairs, respectively, working memory performance in withdrawn and water animals[5].
References

[1]. Su H Hung, et al. A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase. Bioorg Chem. 2002 Feb;30(1):16-31.

[2]. L Y Wang, et al. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science. 1991 Sep 6;253(5024):1132-5.

[3]. Ronald Jäger, et al. Activation of PDE10 and PDE11 phosphodiesterases. J Biol Chem. 2012 Jan 6;287(2):1210-9.

[4]. P A Connelly,et al. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate. J Biol Chem. 1987 Mar 25;262(9):4324-32.

[5]. G Dominguez, et al. Rescuing prefrontal cAMP-CREB pathway reverses working memory deficits during withdrawal from prolonged alcohol exposure. Brain Struct Funct. 2016 Mar;221(2):865-77.

 Chemical & Physical Properties

Molecular Formula C10H11N5NaO5PS
Molecular Weight 367.253
Exact Mass 367.011627
PSA 182.50000
LogP 0.96900

 Synonyms

Sodium (2S,4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2-thiolate 2-oxide
4H-Furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-mercapto-, 2-oxide, sodium salt, (2S,4aR,6R,7R,7aS)- (1:1)
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Sp-cAMPS sodium salt suppliers


Price: ¥3000/5 mg

Reference only. check more Sp-cAMPS sodium salt price

Related Compounds: More...
Rp-cAMPS sodium salt
142439-94-9
8-chloroadenosine-3',5'-cyclic monophosphorothioate, sp-isomer sodium salt
142754-28-7
adenosine-2',3'-cyclic monophosphorothioate, endo/rp-isomer sodium salt
118275-99-3
8-bromoadenosine-3',5'-cyclic monophosphorothioate, rp-isomer sodium salt
129735-00-8
Sp-8-pCPT-cAMPS
129693-13-6
Sp-5,6-dichloro-cBIMPS (sodium salt)
142439-96-1
dodecylphosphonic acid, sodium salt
50869-33-5
trithiocarbonic acid , sodium salt
13472-44-1
Carboxymethyl cellulose sodium salt
117385-93-0
6-(1H-1,2,4-Triazol-1-yl)pyridine-3-carbaldehyde
1007317-56-7
6-Iodomethylcholesterol
86522-55-6
1-(3-Phenylpropyl)piperazin-2-one
198896-29-6
Tert-butyl 4-(3-phenylpropyl)piperazine-1-carboxylate
198895-69-1
2-Chloro-2-methylpropylamine hydrochloride
30533-51-8
5beta-Dihydroaldosterone
7305-52-4
6-Bromo-2,5-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one
90150-96-2
(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-9-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxyoxane-2-carboxylic
234761-05-8
2,3-Bis(4-methoxyphenyl)-2-pentenenitrile, (Z)-
54837-95-5
(2S)-2-amino-3-(1H-pyrazol-4-yl)propanoic acid
2272735-02-9